source Dr. Senthil Thyagarajan
http://changemyvideo.com/redouble/engels-kupit-kokain-mq.html Dr. Senthil Thyagarajan is a scientist & currently, Laboratory & Operations Director with NCORD Biotech Limited, India. Earlier, he was a Postdoctoral Scientist at Abbott Pharmaceuticals, Ludwigshafen, Germany & Max Planck Institute of Neurobiology, Munich, Germany, with particular focus on Stem Cell Biology, Cellular Assays & Developmental Neurobiology, respectively. He is an accomplished, dynamic professional with more than 8 years of experience conducting high-level scientific research. At Abbott Pharmaceuticals, Dr. Thyagarajan was part of the StemBANCC programme, a 5 year research project that involved academic and industry partners across 11 countries, funded by the Innovative Medicines Initiative (IMI) and worked on developing human iPSC derived neural stem cells drug discovery platform.
Dr. Thyagarajan holds a PhD in Neurobiology from the Max Planck Institute for Brain Research, Frankfurt, Germany. His work has been published in International peer-reviewed top Journals and has presented his work in various National and International conferences. Dr. Thyagarajan’s keen interest in clinical and translational research has involved him in regenerative medicine and currently he is working on establishing NCORD’s state-of-the-art stem cell transplantation Center and cellular medicine.
Besides his research calibre, he is motivated by challenge to improve business model for science-driven ventures. At NCORD, he is a proactive leader and team player integral to implementation and efficient running of numerous verticals including NCORD’s Private Cord blood banking, Chain of Blood banks and transfusion centres and a R&D Centre for therapeutic cellular product development division.